CNO Fundamental Analysis - CALIFORNIA NANOTECHNOLOGIES

Fundamental Rating

We assign a fundamental rating of 4 out of 10 to CNO. CNO was compared to 20 industry peers in the Machinery industry. Both the profitability and the financial health of CNO get a neutral evaluation. Nothing too spectacular is happening here. CNO does not seem to be growing, but still is valued expensively.

Quickly go to:

1. Profitability

1.1 Basic Checks

CNO had negative earnings in the past year.

CNO had a positive operating cash flow in the past year.

The reported net income has been mixed in the past 5 years: CNO reported negative net income in multiple years.

In the past 5 years CNO always reported a positive cash flow from operatings.

1.2 Ratios

With a Return On Assets value of -27.36%, CNO is not doing good in the industry: 70.00% of the companies in the same industry are doing better.

CNO has a Return On Equity of -59.99%. This is in the lower half of the industry: CNO underperforms 70.00% of its industry peers.

With a decent Return On Invested Capital value of 7.76%, CNO is doing good in the industry, outperforming 75.00% of the companies in the same industry.

CNO had an Average Return On Invested Capital over the past 3 years of 30.56%. This is significantly above the industry average of 7.51%.

The 3 year average ROIC (30.56%) for CNO is well above the current ROIC(7.76%). The reason for the recent decline needs to be investigated.

		Industry Rank	Sector Rank
ROA	-27.36%
ROE	-59.99%
ROIC	7.76%

ROA(3y)7%

ROA(5y)3.17%

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)30.56%

ROIC(5y)N/A

1.3 Margins

CNO has a better Operating Margin (7.11%) than 75.00% of its industry peers.

CNO's Operating Margin has improved in the last couple of years.

CNO has a Gross Margin of 74.15%. This is amongst the best in the industry. CNO outperforms 100.00% of its industry peers.

CNO's Gross Margin has improved in the last couple of years.

		Industry Rank	Sector Rank
OM	7.11%
PM (TTM)	N/A
GM	74.15%

OM growth 3Y4.57%

OM growth 5Y69.99%

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y1.75%

GM growth 5Y3.23%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so CNO is creating value.

CNO has more shares outstanding than it did 1 year ago.

Compared to 5 years ago, CNO has more shares outstanding

The debt/assets ratio for CNO is higher compared to a year ago.

2.2 Solvency

CNO has an Altman-Z score of 2.61. This is not the best score and indicates that CNO is in the grey zone with still only limited risk for bankruptcy at the moment.

Looking at the Altman-Z score, with a value of 2.61, CNO is in the better half of the industry, outperforming 65.00% of the companies in the same industry.

CNO has a debt to FCF ratio of 1.33. This is a very positive value and a sign of high solvency as it would only need 1.33 years to pay back of all of its debts.

With an excellent Debt to FCF ratio value of 1.33, CNO belongs to the best of the industry, outperforming 95.00% of the companies in the same industry.

A Debt/Equity ratio of 0.58 indicates that CNO is somewhat dependend on debt financing.

With a Debt to Equity ratio value of 0.58, CNO perfoms like the industry average, outperforming 50.00% of the companies in the same industry.

Even though the debt/equity ratio score it not favorable for CNO, it has very limited outstanding debt, so we won't put too much weight on the DE evaluation.

		Industry Rank	Sector Rank
Debt/Equity	0.58
Debt/FCF	1.33
Altman-Z	2.61

ROIC/WACC0.76

WACC10.23%

2.3 Liquidity

CNO has a Current Ratio of 0.92. This is a bad value and indicates that CNO is not financially healthy enough and could expect problems in meeting its short term obligations.

CNO has a Current ratio of 0.92. This is amonst the worse of the industry: CNO underperforms 80.00% of its industry peers.

A Quick Ratio of 0.92 indicates that CNO may have some problems paying its short term obligations.

CNO has a worse Quick ratio (0.92) than 70.00% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	0.92
Quick Ratio	0.92

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

CNO shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -209.47%.

The Revenue has grown by 13.45% in the past year. This is quite good.

The Revenue has been growing by 49.59% on average over the past years. This is a very strong growth!

EPS 1Y (TTM)-209.47%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-165.75%

Revenue 1Y (TTM)13.45%

Revenue growth 3Y79.21%

Revenue growth 5Y49.59%

Sales Q2Q%-59.02%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CNO. In the last year negative earnings were reported.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CNO indicates a somewhat cheap valuation: CNO is cheaper than 80.00% of the companies listed in the same industry.

95.00% of the companies in the same industry are more expensive than CNO, based on the Price/Free Cash Flow ratio.

		Industry Rank	Sector Rank
P/FCF	10.14
EV/EBITDA	12.28

4.3 Compensation for Growth

CNO has a very decent profitability rating, which may justify a higher PE ratio.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2YN/A

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for CNO!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

CALIFORNIA NANOTECHNOLOGIES

TSX-V:CNO (9/2/2025, 7:00:00 PM)

0.34

+0.02 (+4.62%)

Chartmill FA Rating

GICS SectorIndustrials

GICS IndustryGroupCapital Goods

GICS IndustryMachinery

Earnings (Last)N/A N/A

Earnings (Next)N/A N/A

Inst OwnersN/A

Inst Owner ChangeN/A

Ins Owners13.79%

Ins Owner ChangeN/A

Market Cap16.21M

Analysts0

Price TargetN/A

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)N/A

PT rev (3m)N/A

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)N/A

EPS NY rev (3m)N/A

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)N/A

Revenue NY rev (3m)N/A

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	2.27
P/FCF	10.14
P/OCF	3.6
P/B	5.43
P/tB	5.44
EV/EBITDA	12.28

EPS(TTM)-0.04

EYN/A

EPS(NY)N/A

Fwd EYN/A

FCF(TTM)0.03

FCFY9.86%

OCF(TTM)0.09

OCFY27.8%

SpS0.15

BVpS0.06

TBVpS0.06

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-27.36%
ROE	-59.99%
ROCE	10.78%
ROIC	7.76%
ROICexc	8.98%
ROICexgc	8.99%
OM	7.11%
PM (TTM)	N/A
GM	74.15%
FCFM	22.4%

ROA(3y)7%

ROA(5y)3.17%

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)30.56%

ROIC(5y)N/A

ROICexc(3y)60.79%

ROICexc(5y)N/A

ROICexgc(3y)61.38%

ROICexgc(5y)N/A

ROCE(3y)19.86%

ROCE(5y)N/A

ROICexcg growth 3Y-3.97%

ROICexcg growth 5Y27%

ROICexc growth 3Y-3.63%

ROICexc growth 5Y32.06%

OM growth 3Y4.57%

OM growth 5Y69.99%

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y1.75%

GM growth 5Y3.23%

F-Score5

Asset Turnover1.09

Health

		Industry Rank	Sector Rank
Debt/Equity	0.58
Debt/FCF	1.33
Debt/EBITDA	1.25
Cap/Depr	332.29%
Cap/Sales	40.75%
Interest Coverage	250
Cash Conversion	325.91%
Profit Quality	N/A
Current Ratio	0.92
Quick Ratio	0.92
Altman-Z	2.61

F-Score5

WACC10.23%

ROIC/WACC0.76

Cap/Depr(3y)145.85%

Cap/Depr(5y)N/A

Cap/Sales(3y)13.6%

Cap/Sales(5y)N/A

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-209.47%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-165.75%

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)13.45%

Revenue growth 3Y79.21%

Revenue growth 5Y49.59%

Sales Q2Q%-59.02%

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y-68.17%

EBIT growth 3Y87.4%

EBIT growth 5Y154.28%

EBIT Next YearN/A

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y279.82%

FCF growth 3Y80.29%

FCF growth 5Y42.36%

OCF growth 1Y787.9%

OCF growth 3Y173%

OCF growth 5Y84.63%

CALIFORNIA NANOTECHNOLOGIES (CNO.CA) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens